MYELOMA TODAY: Vol 15 No.2 FDA APPROVES REVLIMID( Lenalidomide) for newly dignosed myeloma

REVLIMID with dexamethasone. FDA recommends stem-cell harvesting after the first four cycles of therapy. together with MUCH CLOSER BLOOD-COUNT monitoring.